Catalogo dei prodotti della ricerca

COTTONE, FRANCESCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 763
EU - Europa 208
AS - Asia 83
AF - Africa 4
SA - Sud America 3
OC - Oceania 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 1.064
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 735
SE - Svezia 79
IT - Italia 66
CN - Cina 40
IN - India 31
CA - Canada 26
BG - Bulgaria 23
RO - Romania 13
SG - Singapore 8
DE - Germania 5
IE - Irlanda 5
UA - Ucraina 5
TG - Togo 4
TR - Turchia 4
AR - Argentina 3
AU - Australia 2
FR - Francia 2
GB - Regno Unito 2
MX - Messico 2
NL - Olanda 2
NO - Norvegia 2
AT - Austria 1
BE - Belgio 1
EU - Europa 1
FI - Finlandia 1
LV - Lettonia 1
Totale 1.064
Salva come PNG Salva come JPEG
Città #
Fairfield 126
Woodbridge 75
Ashburn 74
Seattle 72
Cambridge 55
Wilmington 49
Chandler 41
Houston 41
Beijing 28
Rome 26
Sofia 23
Ottawa 22
Princeton 16
Ann Arbor 15
Plano 13
Bologna 11
San Diego 11
Lawrence 7
New York 6
Norwalk 6
Dublin 5
Konya 4
Lomé 4
Millbury 4
San Paolo di Civitate 4
Dearborn 3
Federal 3
Hefei 3
Kunming 3
Toronto 3
Trento 3
Andover 2
As 2
Bühl 2
Cagliari 2
Charlottesville 2
Des Moines 2
Falls Church 2
Fuzhou 2
Groningen 2
Hobart 2
Mexico City 2
Santa Maria A Vico 2
Singapore 2
Ang Mo Kio 1
Ariccia 1
Barano d'Ischia 1
Boardman 1
Boston 1
Bremen 1
Brussels 1
Cormeilles-en-Parisis 1
Dortmund 1
Guangzhou 1
Harbin 1
Helsinki 1
Hyderabad 1
Jinan 1
Las Vegas 1
London 1
Montreal 1
Phoenix 1
Redwood City 1
Riga 1
St Louis 1
Trumbull 1
Vienna 1
Washington 1
Totale 806
Salva come PNG Salva come JPEG
Nome #
Evaluating methodological quality of Prognostic models Including Patient-reported HeAlth outcomes in oncologY (EPIPHANY): A systematic review protocol 88
The prognostic value of patient-reported outcomes (PROs) for survival outcomes in cancer patients: A systematic review 86
Modelling strategies to improve estimates of prognostic factors analyses with patient reported outcomes: a simulation study 77
Modeling strategies to improve parameter estimates in prognostic factors analyses with patient-reported outcomes in oncology 77
Randomized Phase III trial of retinoic acid and arsenic trioxide versus retinoic acid and chemotherapy in patients with acute promyelocytic leukemia: Health-related quality-of-life outcomes 74
PCN368 - CONCORDANCE BETWEEN PATIENTS AND CLINICIANS’ REPORTING OF SYMPTOMATIC ADVERSE EVENTS IN CANCER CLINICAL TRIALS: A SYSTEMATIC REVIEW 68
Patient- versus physician-reporting of symptoms and health status in chronic myeloid leukemia 66
Concordance between patient reported and clinical outcomes in randomized controlled trials (RCTs) of cancer treatment 66
Distribution- and anchor-based methods to determine the minimally important difference on patient-reported outcome questionnaires in oncology: a structured review 63
null 60
null 52
null 51
null 50
null 49
null 49
null 46
Clinician-reported symptomatic adverse events in cancer trials: are they concordant with patient-reported outcomes? 14
Patient-reported outcomes enhance the survival prediction of traditional disease risk classifications: An international study in patients with myelodysplastic syndromes 13
Health-related quality of life in patients with chronic myeloid leukemia receiving first-line therapy with nilotinib 12
Health-related quality of life, symptom burden, and comorbidity in long-term survivors of acute promyelocytic leukemia 12
Validation of the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire Core 30 Summary Score in Patients With Hematologic Malignancies 11
Prognostic value of self-reported fatigue on overall survival in patients with myelodysplastic syndromes: a multicentre, prospective, observational, cohort study 9
Physicians' attitude towards selection of second line therapy with nilotinib and dasatinib in chronic myeloid leukemia patients 8
Pretreatment Health-Related Quality of Life Profile According to the EORTC QLQ-C30 in Patients with Myelodysplastic Syndromes (MDS): Analysis on 443 Lower-Risk MDS Patients 8
Health-related quality of life of newly diagnosed chronic myeloid leukemia patients treated with first-line dasatinib versus imatinib therapy 7
Patient-Reported Outcomes Enhance the Survival Prediction of Traditional Disease Risk Classifications: An International Study in Patients With Myelodysplastic Syndromes 6
Pretreatment symptom prevalence in patients with myelodysplastic syndromes (MDS) across all disease risk categories: Analysis of 914 patients 5
Association of IMWG frailty score with health-related quality of life profile of patients with relapsed refractory multiple myeloma in Italy and the UK: a GIMEMA, multicentre, cross-sectional study 5
Health-related quality of life of newly diagnosed chronic myeloid leukemia patients treated with first-line dasatinib versus imatinib therapy 4
Younger age at diagnosis of acute promyelocytic leukaemia is associated with better long-term cognitive functioning 4
Validation and reference values of the EORTC QLQ-CML24 questionnaire to assess health-related quality of life in patients with chronic myeloid leukemia 4
Fatigue in long-term survivors of acute promyelocytic leukemia (APL) and its association with other symptoms and functional limitations 4
The IPSS-R more accurately captures fatigue severity of newly diagnosed patients with myelodysplastic syndromes compared with the IPSS index 2
Totale 1.150
Salva come PNG Salva come JPEG
Categoria #
all - tutte 2.855
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.855
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019124 0 0 0 0 0 0 0 0 0 26 48 50
2019/2020357 33 9 5 14 41 45 50 54 39 30 26 11
2020/202197 30 15 2 11 2 8 2 3 8 4 4 8
2021/2022218 24 1 3 15 33 22 1 20 8 16 60 15
2022/2023199 38 30 11 8 40 22 14 16 10 1 5 4
2023/2024124 14 20 4 13 13 30 5 9 1 15 0 0
Totale 1.150